Aspergillus terreus accessory conidia are unique in surface architecture, cell wall composition and germination kinetics

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Deak, Eszter ^a   Wilson, Selwyn D ^a   White, Elizabeth ^a   Carr, Janice H ^a   Balajee, S Arunmozhi ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; BETA 1,3 GLUCAN; ERGOSTEROL; ANTIFUNGAL AGENT; BETA GLUCAN;

ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONIDIUM; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GERMINATION; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; TRANSMISSION ELECTRON MICROSCOPY; ASPERGILLUS; BIOLOGICAL MODEL; CELL WALL; CHEMISTRY; FUNGUS SPORE; GENE EXPRESSION REGULATION; KINETICS; METABOLISM; METHODOLOGY; PHYSIOLOGY; SCANNING ELECTRON MICROSCOPY;

ASPERGILLUS; ASPERGILLUS TERREUS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS; BETA-GLUCANS; CELL WALL; ERGOSTEROL; GENE EXPRESSION REGULATION, FUNGAL; GERMINATION; KINETICS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, BIOLOGICAL; PHENOTYPE; SPORES, FUNGAL;

EID: 70449578289     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007673     Document Type: Article

References (26)

1. Magill SS, Chiller TM, Warnock DW (2008) Evolving strategies in the management of aspergillosis. Expert Opin Pharmacother 9: 193-209.
2. Malani AN, Kauffman CA (2007) Changing epidemiology of rare mould infections: implications for therapy. Drugs 67: 1803-1812.
3. Steinbach WJ, Benjamin DK, Jr., Kontoyiannis DP, Perfect JR, Lutsar I, et al. (2004) Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis 39: 192-198.
4. Walsh TJ, Petraitis V, Petraitiene R, Field-Ridley A, Sutton D, et al. (2003) Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J Infect Dis 188: 305-319.
5. Raper BK, Fennell DI (1965) The Genus Aspergillus. Baltimore, Md: The Williams and Wilkins Company. 657 p.
6. Ainsworth GC, PKCA (1955) A survey of animal mycoses in Britain: General aspects. Vet Record 67: 88-97.
7. Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, et al. (2004) Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 10 Suppl 1: 48-66.
8. Lass-Florl C, Rief A, Leitner S, Speth C, Wurzner R, et al. (2005) In vitro activities of amphotericin B and voriconazole against aleurioconidia from Aspergillus terreus. Antimicrob Agents Chemother 49: 2539-2540.
9. Girardin H, Paris S, Rault J, Bellon-Fontaine MN, Latge JP (1999) The role of the rodlet structure on the physicochemical properties of Aspergillus conidia. Lett Appl Microbiol 29: 364-369.
10. Sande WV, Tavakol M, Vianen WV, Bakker-Woudenberg IA (2009) The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus. Med Mycol. pp 1-8.
11. Arthington-Skaggs BA, Jradi H, Desai T, Morrison CJ (1999) Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol 37: 3332-3337.
12. Arthington-Skaggs BA, Warnock DW, Morrison CJ (2000) Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis. Antimicrob Agents Chemother 44: 2081-2085.
13. Clinical (2002) Reference Method for Broth dilution Antifungal Susceptibility Testing of Conidium-forming Filamentous Fungi: Approved Standard M38-A. Wayne, PA: CLSI.
14. Balajee SA, Marr KA (2002) Conidial viability assay for rapid susceptibility testing of Aspergillus species. J Clin Microbiol 40: 2741-2745.
15. Bernard M, Latge JP (2001) Aspergillus fumigatus cell wall: composition and biosynthesis. Med Mycol 39 Suppl 1: 9-17.
16. Latge JP, Debeaupuis JP, Sarfati J, Diaquin M, Paris S (1993) Cell wall antigens in Aspergillus fumigatus. Arch Med Res 24: 269-274.
17. Thau N, Monod M, Crestani B, Rolland C, Tronchin G, et al. (1994) rodletless mutants of Aspergillus fumigatus. Infect Immun 62: 4380-4388.
18. Moss BJ, Kim Y, Nandakumar MP, Marten MR (2008) Quantifying metabolic activity of filamentous fungi using a colorimetric XTT assay. Biotechnol Prog 24: 780-783.
19. Iwen PC, Rupp ME, Langnas AN, Reed EC, Hinrichs SH (1998) Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature. Clin Infect Dis 26: 1092-1097.
20. Sterling TR, Merz WG (1998) Resistance to amphotericin B: emerging clinical and microbiological patterns. Drug Resist Updat 1: 161-165.
21. Dannaoui E, Borel E, Persat F, Piens MA, Picot S (2000) Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis. J Med Microbiol 49: 601-606.
22. Hohl TM, Van Epps HL, Rivera A, Morgan LA, Chen PL, et al. (2005) Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog 1: e30.
23. Wheeler RT, Kombe D, Agarwala SD, Fink GR (2008) Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment. PLoS Pathog 4: e1000227.
24. Luther K, Torosantucci A, Brakhage AA, Heesemann J, Ebel F (2007) Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin-1 beta-glucan receptor and Toll-like receptor 2. Cell Microbiol 9: 368-381.
25. Gantner BN, Simmons RM, Underhill DM (2005) Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 24: 1277-1286.
26. Langfelder K, Jahn B, Gehringer H, Schmidt A, Wanner G, et al. (1998) Identification of a polyketide synthase gene (pksP) of Aspergillus fumigatus involved in conidial pigment biosynthesis and virulence. Med Microbiol Immunol 187: 79-89.